SAR-COV-2

Clinical trials for SAR-COV-2 explained in plain language.

Never miss a new study

Get alerted when new SAR-COV-2 trials appear

Sign up with your email to follow new studies for SAR-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a single pill shorten the flu? new trial aims to find out

Symptom relief Not yet recruiting

This phase 3 trial tests whether a single dose of baloxavir helps non-hospitalized adults with mild-to-moderate influenza recover faster compared to a placebo. About 264 participants will be enrolled within 5 days of symptoms and tracked until they feel fully recovered. The study…

Matched conditions: SAR-COV-2

Phase: PHASE3 • Sponsor: Unity Health Toronto • Aim: Symptom relief

Last updated Jun 27, 2026 08:08 UTC

SAR-COV-2

Get alerted when new SAR-COV-2 trials appear

Could a single pill shorten the flu? new trial aims to find out